Liven Pharma Limited (PSX:LIVEN)
Pakistan · Delayed Price · Currency is PKR 38.65
+0.03 (0.08%)
At close: Jun 4, 2026
Liven Pharma Income Statement
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 99.11 | 127.27 | 245.09 | - | - | - | |
Revenue Growth (YoY) | -72.91% | -48.07% | - | - | - | - |
Cost of Revenue | 90.97 | 111.45 | 182.96 | - | - | - |
Gross Profit | 8.14 | 15.82 | 62.14 | - | - | - |
Selling, General & Admin | 390.68 | 389.03 | 19.14 | 2.12 | 2.95 | 2.1 |
Other Operating Expenses | 120.14 | 88.84 | 1.23 | - | - | - |
Operating Expenses | 540.49 | 507.53 | 20.37 | 15.22 | 17.51 | 18.19 |
Operating Income | -532.35 | -491.71 | 41.77 | -15.22 | -17.51 | -18.19 |
Interest Expense | -2.27 | -0.73 | -0.02 | - | - | - |
Interest & Investment Income | 0.63 | 0.31 | - | - | - | - |
Other Non Operating Income (Expenses) | -33.82 | -0.06 | -0 | -0 | -0 | -0 |
EBT Excluding Unusual Items | -567.81 | -492.19 | 41.74 | -15.23 | -17.51 | -18.19 |
Pretax Income | -643.3 | -492.19 | 41.74 | -15.23 | -17.51 | -18.19 |
Income Tax Expense | 57.92 | 92.27 | - | -2.9 | -3.22 | -3.55 |
Net Income | -701.22 | -584.46 | 41.74 | -12.33 | -14.29 | -14.63 |
Net Income to Common | -701.22 | -584.46 | 41.74 | -12.33 | -14.29 | -14.63 |
Shares Outstanding (Basic) | 90 | 70 | 0 | 12 | 12 | 12 |
Shares Outstanding (Diluted) | 90 | 70 | 0 | 12 | 12 | 12 |
Shares Change (YoY) | 172.01% | 174375.69% | -99.67% | - | - | - |
EPS (Basic) | -7.80 | -8.37 | 1043.60 | -1.02 | -1.18 | -1.21 |
EPS (Diluted) | -7.80 | -8.37 | 1043.60 | -1.02 | -1.18 | -1.21 |
Free Cash Flow | 184.72 | -24.56 | 13.8 | -2.27 | -2.26 | -6.79 |
Free Cash Flow Per Share | 2.05 | -0.35 | 345.08 | -0.19 | -0.19 | -0.56 |
Gross Margin | 8.21% | 12.43% | 25.35% | - | - | - |
Operating Margin | -537.14% | -386.34% | 17.04% | - | - | - |
Profit Margin | -707.52% | -459.22% | 17.03% | - | - | - |
Free Cash Flow Margin | 186.39% | -19.30% | 5.63% | - | - | - |
EBITDA | -505.26 | -465.93 | 64.93 | -2.12 | -2.95 | -2.1 |
EBITDA Margin | - | - | 26.49% | - | - | - |
D&A For EBITDA | 27.09 | 25.78 | 23.16 | 13.1 | 14.56 | 16.08 |
EBIT | -532.35 | -491.71 | 41.77 | -15.22 | -17.51 | -18.19 |
EBIT Margin | - | - | 17.04% | - | - | - |
Advertising Expenses | - | 3.26 | 0.12 | - | - | - |